Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 3Breast 3Gastrointestinal 2Other solid neoplasm 1Lymphoid 1Gynecologic 1CNS 1

Conditions

Fasting 2Intermittent Fasting 1Fibrosis 1Esophageal Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Angptl4 protein, mouse × Gastrointestinal × Clear all
NCT04247464 2023-10-05

CHEMOFAST

IMDEA Food

Phase NA Completed
11 enrolled
Gastrointestinal

Intermittent Fasting, Fasting, Colorectal Neoplasms

NCT03706846 2018-10-16

GASTROPREP

Centre Hospitalier Universitaire de Besancon

Phase NA Completed
70 enrolled
Gastrointestinal

Esophageal Neoplasms, Fasting, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡